Bryan J. McMichael - 04 Jan 2023 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role: Title: Senior Vice President, Accounting, Corporate Controller and Principal Accounting Officer
Signature: /s/ McDavid Stilwell, as Attorney-in-Fact for Bryan J. McMichael
Issuer symbol: CHRS
Transactions as of: 04 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 06 Jan 2023, 17:16:29 UTC
Previous filing: 09 Sep 2022
Next filing: 10 Jan 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CHRS	Stock Option (Right to Buy)	Award	$0	+25,000		$0.000000	25,000	04 Jan 2023	Common Stock	25,000	$9.87	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Remarks:

Title: Senior Vice President, Accounting, Corporate Controller and Principal Accounting Officer